市場調查報告書

靜脈內輸液幫浦市場規模,佔有率,趨勢分析:2020年∼2027年

Intravenous Infusion Pump Market Size, Share & Trends Analysis Report By Product (Volumetric, Insulin, Syringe, Enteral, Ambulatory), By Disease Indication, By Region, And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 940757
出版日期 內容資訊 英文 100 Pages
商品交期: 2-3個工作天內
價格
靜脈內輸液幫浦市場規模,佔有率,趨勢分析:2020年∼2027年 Intravenous Infusion Pump Market Size, Share & Trends Analysis Report By Product (Volumetric, Insulin, Syringe, Enteral, Ambulatory), By Disease Indication, By Region, And Segment Forecasts, 2020 - 2027
出版日期: 2020年05月18日內容資訊: 英文 100 Pages
簡介

全球靜脈內輸液幫浦市場規模在2027年前預測將達到22億6000萬美元,在預測期間內的年複合成長率預計將為5.9%。

本報告提供全球靜脈內輸液幫浦市場相關調查分析,提供市場概要,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 調查手法和範圍

第2章 摘要整理

第3章 靜脈內輸液幫浦市場變數·趨勢·範圍

  • 市場系統預測
  • 普及率和成長預測製圖
  • 市場動態
  • 靜脈內輸液幫浦:市場分析工具

第4章 靜脈內輸液幫浦市場:各市場區隔分析 - 各產品

  • 定義和範圍
  • 各產品的市場佔有率分析
  • 市場區隔儀表板
  • 全球靜脈內輸液幫浦市場:各產品
  • 市場規模與預測·趨勢分析

第5章 靜脈內輸液幫浦市場:各市場區隔分析 - 各疾病適應症

  • 定義和範圍
  • 各疾病適應症的市場佔有率分析
  • 市場區隔儀表板
  • 全球靜脈內輸液幫浦市場:各疾病適應症
  • 市場規模與預測·趨勢分析

第6章 靜脈內輸液幫浦市場:各地區的市場分析

  • 定義和範圍
  • 各地區的市場佔有率分析
  • 各地區的市場儀表板
  • 各地區的市場概述
  • 各地區的市場佔有率
  • 市場規模與預測·趨勢分析
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 靜脈內輸液幫浦市場:競爭分析

  • 主要企業的簡介
目錄
Product Code: GVR-4-68038-560-1

Intravenous Infusion Pumps Market Growth & Trends

The global intravenous infusion pumps market size is expected to reach USD 2.26 billion by 2027, registering a CAGR of 5.9% over the forecast period according to a new report by Grand View Research, Inc. The introduction and development of specialty and smart pumps are imparting crucial growth of the market as they constitutes Dose-error Reduction Software (DERS) and customized drug libraries. According to a study conducted by Mindray Medical Company in 2018, medical pumps are the most conventional hospital rentals equipment.

To improve the safety and efficacy of intravenous infusion pumps, the U.S. FDA took an initiative known as the Infusion Pump Improvement Initiative in 2010, which focuses on supporting the benefits of generic pumps and minimizing the risk associated with it at the same time. FDA also launched a website that gives peculiar information about medical pumps to the patients, users, and other stakeholders. Several government collaborative researchprojects like the Generic Infusion Pump Project are introduced that are aimed at creating new methods for manufacturers for developing software for intravenous medical pumps. National Institute of Standards and Technology is working in collaboration with NCCoE to manufacture wireless medical pumps and such incorporation of various government policies and regulations will in turn propel the market.

The amalgamation of factors like the shift in technology, automation, and standardized dosing for the intravenous medical devices are anticipated to make therapy more convenient and user-friendly for patients. For instance, in May 2018, Baxter launched SPECTRUM IQ that allows patients records to be transferred directly from the EMR to the infusion system which is apt for home therapy as well as for therapies carried out in hospitals.

The haematology disease indication segment is anticipated to grow fast over the forecast period. Rising cases of blood cancer is driving demand for blood transfusion through haematology, thereby driving the segment. North America dominated the market in 2019 and is anticipated to maintain its dominance over the forecast period. Increasing number of surgeries, rising cases of chronic diseases, and R&D in healthcare sector is driving the market in the region.

Intravenous Infusion Pumps Market Report Highlights

Ambulatory infusion pumps emerged as the largest product segment in 2019 owing to increasing use of delivery fluids such as nutrients and medications in case of emergencies and treatments like chemotherapy

The implantable infusion pumps segment is projected to register the highest CAGR over the forecast period as they offer advantages such as improved safety

The pediatrics/ neonatology segment dominated the market in 2019 in terms of disease indication as there has been growing incidences of premature birth and hence require optimum care and nutrition

In Asia Pacific, the market is projected to witness the fastest growth over the forecast period owing to the increasing number of geriatric and diabetic patients in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Disease Indication
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1: Understanding the market dynamics
    • 1.9.2. Objective 2: Understanding the market estimates and forecasts
    • 1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
    • 1.9.4. Objective 4: Understanding the key product and Disease Indication scopes to conclude on the market size

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Intravenous Infusion Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Increasing geriatric population
      • 3.3.1.2. Rising prevalence of chronic diseases
      • 3.3.1.3. Recent technological advancements in infusion pumps
      • 3.3.1.4. Home healthcare as cost effective alternative
      • 3.3.1.5. Improving healthcare infrastructure in emerging economies
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Product recall
      • 3.3.2.2. Presence of complicated reimbursement framework and reimbursement cuts
    • 3.3.3. Industry Challenges
      • 3.3.3.1. Rising cost of Intravenous Infusion Pumps
  • 3.4. Intravenous Infusion Pumps: Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier Power
      • 3.4.1.2. Buyer Power
      • 3.4.1.3. Substitution Threat
      • 3.4.1.4. Threat from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political Landscape
      • 3.4.2.2. Environmental Landscape
      • 3.4.2.3. Social Landscape
      • 3.4.2.4. Technology Landscape
      • 3.4.2.5. Legal Landscape
    • 3.4.3. Major Deals & Strategic Alliances Analysis

Chapter 4. Intravenous Infusion Pumps Market: Segment Analysis, by Product, 2016 - 2027 (USD Million)

  • 4.1. Definitions & Scope
  • 4.2. Product market share analysis, 2019 & 2027
  • 4.3. Segment Dashboard
  • 4.4. Global Intravenous Infusion Pumps Market , by Product, 2016 to 2027
  • 4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027for the following
    • 4.5.1. By product
      • 4.5.1.1. Volumetric Infusion pumps
      • 4.5.1.2. Insulin Infusion pumps
      • 4.5.1.3. Syringe Infusion pumps
      • 4.5.1.4. Enteral Infusion pumps
      • 4.5.1.5. Ambulatory Infusion pumps
      • 4.5.1.6. Patient Controlled Analgesics (PCA)
      • 4.5.1.7. Implantable Infusion pumps
      • 4.5.1.8. Others

Chapter 5. Intravenous Infusion Pumps Market: Segment Analysis, By Disease Indication, 2016 - 2027 (USD Million)

  • 5.1. Definitions & Scope
  • 5.2. Disease Indication market share analysis, 2019 & 2027
  • 5.3. Segment Dashboard
  • 5.4. Global Intravenous Infusion Pumps Market, By Disease Indication, 2016 to 2027
  • 5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
    • 5.5.1. Chemotherapy
    • 5.5.2. Diabetes
    • 5.5.3. Gastroenterology
    • 5.5.4. Analgesia/Pain Management
    • 5.5.5. Pediatrics/Neonatology
    • 5.5.6. Hematology
    • 5.5.7. Others

Chapter 6. Intravenous Infusion Pumps Market: Regional Market Analysis, by Product, 2016 - 2027 (USD Million)

  • 6.1. Definitions & Scope
  • 6.2. Regional Market Share Analysis, 2019 & 2027
  • 6.3. Regional Market Dashboard
  • 6.4. Regional Market Snapshot
  • 6.5. Regional Market Share, 2018
  • 6.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
  • 6.7. North America
    • 6.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.7.2. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
    • 6.7.3. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.7.4. U.S.
      • 6.7.4.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.7.4.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.7.5. Canada
      • 6.7.5.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.7.5.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
  • 6.8. Europe
    • 6.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.8.2. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
    • 6.8.3. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.8.4. Germany
      • 6.8.4.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.8.4.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.8.5. U.K.
      • 6.8.5.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.8.5.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.8.6. France
      • 6.8.6.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.8.6.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.8.7. Italy
      • 6.8.7.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.8.7.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.8.8. Spain
      • 6.8.8.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.8.8.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.8.9. Netherlands
      • 6.8.9.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.8.9.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.8.10. Belgium
      • 6.8.10.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.8.10.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.8.11. Switzerland
      • 6.8.11.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.8.11.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.8.12. Russia
      • 6.8.12.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.8.12.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.8.13. Sweden
      • 6.8.13.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.8.13.2 Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
  • 6.9. Asia Pacific
    • 6.9.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.9.2. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
    • 6.9.3. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.9.4. China
      • 6.9.4.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.9.4.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.9.5. Japan
      • 6.9.5.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.9.5.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.9.6. India
      • 6.9.6.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.9.6.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.9.7. Australia
      • 6.9.7.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.9.7.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.9.8. South Korea
      • 6.9.8.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.9.8.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.9.9. Malaysia
      • 6.9.9.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.9.9.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.9.10. Indonesia
      • 6.9.10.1. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.9.10.2. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.9.11 Singapore
      • 6.9.11.3. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.9.11.4. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.9.12 Philippines
      • 6.9.12.5. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.9.12.6. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.9.13 Thailand
      • 6.9.13.7. Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.9.13.8. Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
  • 6.10 Latin America
    • 6.10.1 Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.10.2 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
    • 6.10.3 Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.10.4 Brazil
      • 6.10.4.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.10.4.2 Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.10.5 Mexico
      • 6.10.5.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.10.5.2 Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.10.6 Argentina
      • 6.10.6.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.10.6.2 Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.10.7 Colombia
      • 6.10.7.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.10.7.2 Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.10.8 Chile
      • 6.10.8.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.10.8.2 Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
  • 6.11 Middle East and Africa
    • 6.11.1 Market estimates and forecast, by country, 2016 - 2027 (USD Million)
    • 6.11.2 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
    • 6.11.3 Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.11.4 South Africa
      • 6.11.4.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.11.4.2 Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.11.5 Saudi Arabia
      • 6.11.5.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.11.5.2 Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.11.6 UAE
      • 6.11.6.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.11.6.2 Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.11.7 Israel
      • 6.11.7.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.11.7.2 Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)
    • 6.11.8 Egypt
      • 6.11.8.1 Market estimates and forecast, by Product, 2016 - 2027 (USD Million)
      • 6.11.8.2 Market estimates and forecast, by Disease Indication, 2016 - 2027 (USD Million)

Chapter 7 Intravenous Infusion Pumps Market - Competitive Analysis

  • 7.1 Key companies profiled
    • 7.1.1 Baxter International
      • 7.1.1.1 Company Overview
      • 7.1.1.2 Financial Performance
      • 7.1.1.3 Product Benchmarking
      • 7.1.1.4 Strategic Initiatives
    • 7.1.2 B. Braun Melsungen AG
      • 7.1.2.1 Company Overview
      • 7.1.2.2 Financial Performance
      • 7.1.2.3 Product Benchmarking
      • 7.1.2.4 Strategic Initiatives
    • 7.1.3 Medtronic
      • 7.1.3.1 Company Overview
      • 7.1.3.2 Financial Performance
      • 7.1.3.3 Product Benchmarking
      • 7.1.3.4 Strategic Initiatives
    • 7.1.4 Micrel Medical Devices Sa
      • 7.1.4.1 Company Overview
      • 7.1.4.2 Financial Performance
      • 7.1.4.3 Product Benchmarking
      • 7.1.4.4 Strategic Initiatives
    • 7.1.5 Fresenius Kabi
      • 7.1.5.1 Company Overview
      • 7.1.5.2 Financial Performance
      • 7.1.5.3 Product Benchmarking
      • 7.1.5.4 Strategic Initiatives
    • 7.1.6 Boston Scientific corporation
      • 7.1.6.1 Company Overview
      • 7.1.6.2 Financial Performance
      • 7.1.6.3 Product Benchmarking
      • 7.1.6.4 Strategic Initiatives
    • 7.1.7 CAREFUSION CORPORATION
      • 7.1.7.1 Company Overview
      • 7.1.7.2 Financial Performance
      • 7.1.7.3 Product Benchmarking
      • 7.1.7.4 Strategic Initiatives
    • 7.1.8 Smiths Medical
      • 7.1.8.1 Company Overview
      • 7.1.8.2 Financial Performance
      • 7.1.8.3 Product Benchmarking
      • 7.1.8.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Intravenous Infusion Pumps Market, By Region 2016 - 2027 (USD Million)
  • Table 4 Global Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 5 Global Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 6 North America Intravenous Infusion Pumps Market, By Country, 2016 - 2027 (USD Million)
  • Table 7 North America Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 8 North America Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 9 U.S. Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 10 U.S. Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 11 Canada Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 12 Canada Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 13 Europe Intravenous Infusion Pumps Market, By Country, 2016 - 2027 (USD Million)
  • Table 14 Europe Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 15 Europe Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 16 U.K. Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 17 U.K. Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 18 Germany Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 19 Germany Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 20 France Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 21 France Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 22 Italy Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 23 Italy Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 24 Spain Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 25 Spain Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 26 Netherlands Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 27 Netherlands Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 28 Belgium Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 29 Belgium Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 30 Switzerland Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 31 Switzerland Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 32 Russia Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 33 Russia Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 34 Sweden Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 35 Sweden Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 36 Asia Pacific Intravenous Infusion Pumps Market, By Country, 2016 - 2027 (USD Million)
  • Table 37 Asia Pacific Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 38 Asia Pacific Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 39 India Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 40 India Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 41 Japan Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 42 Japan Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 43 China Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 44 China Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 45 Australia Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 46 Australia Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 47 South Korea Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 48 South Korea Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 49 Malaysia Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 50 Malaysia Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 51 Indonesia Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 52 Indonesia Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 53 Singapore Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 54 Singapore Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 55 Philippines Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 56 Philippines Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 57 Thailand Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 58 Thailand Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 59 Latin America Intravenous Infusion Pumps Market, By Country, 2016 - 2027 (USD Million)
  • Table 60 Latin America Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 61 Latin America Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 62 Brazil Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 63 Brazil Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 64 Mexico Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 65 Mexico Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 66 Argentina Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 67 Argentina Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 68 Colombia Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 69 Colombia Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 70 Chile Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 71 Chile Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 72 MEA Intravenous Infusion Pumps Market, By Country, 2016 - 2027 (USD Million)
  • Table 73 MEA Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 74 MEA Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 75 South Africa Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 76 South Africa Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 77 Saudi Arabia Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 78 Saudi Arabia Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 79 UAE Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 80 UAE Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 81 Israel Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 82 Israel Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)
  • Table 83 Egypt Intravenous Infusion Pumps Market, By Product, 2016 - 2027 (USD Million)
  • Table 84 Egypt Intravenous Infusion Pumps Market, By Disease Indication, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Intravenous Infusion Pumps Market: Market snapshot
  • Fig. 9 Intravenous Infusion Pumps Market: Market segmentation
  • Fig. 10 Intravenous Infusion Pumps Market Strategy framework
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Intravenous Infusion Pumps Market driver impact
  • Fig. 14 Intravenous Infusion Pumps Market restraint impact
  • Fig. 15 Intravenous Infusion Pumps Market Porter's Five Forces Analysis
  • Fig. 16 Intravenous Infusion Pumps Market PESTEL analysis
  • Fig. 17 Intravenous Infusion Pumps Market segment dashboard
  • Fig. 18 Intravenous Infusion Pumps Market: Product Movement Analysis
  • Fig. 19 Infusion pumps estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 20 Intravenous Sets estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 21 IV cannulas estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 22 Volumetric Infusion Pumps estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 23 Insulin Infusion Pumps Market segment dashboard
  • Fig. 24 Intravenous Infusion Pumps Market: Disease Indication Movement Analysis
  • Fig. 25 Chemotherapy market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 26 Endocrinology market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 27 Diabetes market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 28 Gastroenterology market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 29 Analgesia/ Pain management market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 30 Pediatrics/neonatology market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 31 Hematology market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 32 Others market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 33 Global Intravenous Infusion Pumps Market: Regional movement analysis
  • Fig. 34 Global Intravenous Infusion Pumps Market: Regional outlook and key takeaways
  • Fig. 35 Global market share, by region
  • Fig. 36 North America market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 37 U.S. market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 38 Canada market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 39 Europe market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 40 U.K. market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 41 Germany market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 42 France market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 43 Italy market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 44 Spain market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 45 Netherlands market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 46 Belgium market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 47 Switzerland market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 48 Russia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 49 Sweden market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 50 Asia Pacific market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 51 China market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 52 Japan market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 53 India market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 54 Australia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 55 South Korea market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 56 Malaysia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 57 Indonesia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 58 Singapore market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 59 Philippines market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 60 Thailand market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 61 Latin America market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 62 Brazil market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 63 Mexico market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 64 Argentina market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 65 Colombia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 66 Chile market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 67 Middle East and Africa. market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 68 South Africa market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 69 Saudi Arabia market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 70 UAE market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 71 Israel market estimates and forecast, 2016 - 2027 (USD Million)
  • Fig. 72 Egypt market estimates and forecast, 2016 - 2027 (USD Million)